✦ LIBER ✦

Calmodulin, a regulatory partner of the estrogen receptor alpha in breast cancer cells

✍ Scribed by Dominique Gallo; Yves Jacquot; Guy Laurent; Guy Leclercq

Book ID: 116734323
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 433 KB
Volume: 291
Category: Article
ISSN: 0303-7207
DOI: 10.1016/j.mce.2008.04.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of estrogen receptor alpha in m

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells

✍ Zhinong Jiang, Junlan Guo, Jianguo Shen… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 771 KB

Hakai acts as a coregulator of estrogen

Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells

✍ Eun-Yeung Gong; Eunsook Park; Keesook Lee 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Interaction Between Estrogen Receptor Al

Interaction Between Estrogen Receptor Alpha, Ionizing Radiation and (anti-) Estrogens in Breast Cancer Cells

✍ R. A. Toillon; N. Magné; I. Laïos; M. Lacroix; H. Duvillier; L. Lagneaux; D. Dev 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 366 KB

A genome-wide study of the repressive ef

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells

✍ Williams, C; Edvardsson, K; Lewandowski, S A; Ström, A; Gustafsson, J-Å 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 428 KB

The Ah receptor inhibits estrogen-induce

The Ah receptor inhibits estrogen-induced estrogen receptor β in breast cancer cells

✍ Silke Kietz; Jane S Thomsen; Jason Matthews; Katarina Pettersson; Anders Ström; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 379 KB

Expression of estrogen receptor alpha in

Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells

✍ Nadine A. Binai; Annette Damert; Gert Carra; Stephan Steckelbroeck; Johannes Löw 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 816 KB

## Abstract Adipositas correlates with an enhanced risk of developing malignant diseases such as breast cancer, endometrial tumor or prostate carcinoma, but the molecular basis for this is not well understood. Potential mechanisms include increased bioavailability of adipocytokines (__e.g.__ leptin